Singapore – June 13, 2025 – The DPIN Foundation announced that its strategic partnership with Nanyang Biologics (NYB) has made substantial progress. Currently, it is continuously empowering Nanyang Biologics' cutting-edge research projects through its stable, efficient, and secure GPU computing network.
This successful application practice marks the verification of DPIN's computing network service capability through real, complex, and high-standard scientific computing scenarios. The smooth progress of the collaboration highlights the consensus and synergistic effect between both parties in the layout of forward-looking technologies.
About DPIN
The DPIN Foundation is committed to integrating global idle GPU resources and building an open, transparent, and accessible global computing network through the deep integration of AI and DePIN (Decentralized Physical Infrastructure Network) technology. Its core mission is to break the computing monopoly of traditional cloud computing giants, addressing the core pain points of high AI computing costs, and difficulties in ensuring data privacy and sovereignty, providing strong computing support for global AI research, cloud gaming, deep learning, and other fields.
About Nanyang Biologics
Nanyang Biologics is an innovative biotechnology company that combines traditional cultural wisdom with modern cutting-edge technology. The company utilizes its proprietary Drug-Target Interaction Graph Neural Network (DTIGN) technology to simulate molecular interactions at the atomic level to identify bioactive compounds with enormous potential. By combining profound insights from nature with advanced artificial intelligence technology, Nanyang Biologics aims to accelerate the compound discovery process for the next generation of health and wellness products.